Evidence map›Paper›PMID 30784189›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2019

Polylactic-co-glycolic acid microspheres added to fixative cements and its role on bone infected architecture.

Blanca Ibarra, Joaquin García-García, Galo Azuara, Blanca Vázquez-Lasa, Miguel A Ortega, Ángel Asúnsolo, Julio San Román, Julia Buján, Natalio García-Honduvilla, Basilio De la Torre

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Polylactic-co-glycolic acid microspheres added to fixative cements and its role on bone infected architecture.Journal of biomedical materials research. Part B, Applied biomaterials · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Blanca IbarraDepartments of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Joaquin García-GarcíaService of Orthopedic Surgery of University Hospital Principe de Asturias, Madrid, Spain.
Galo AzuaraService of Traumatology of University Hospital of Guadalajara, Madrid, Spain.
Blanca Vázquez-LasaNetworking Biomedical Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Polymer Science and Technology (ICTP-CSIC), Madrid, Spain.
Miguel A OrtegaDepartments of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Ángel AsúnsoloDepartment of Surgery, Medical and Social Sciences, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Julio San RománNetworking Biomedical Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Institute of Polymer Science and Technology (ICTP-CSIC), Madrid, Spain.
Julia BujánDepartments of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Natalio García-HonduvillaDepartments of Medicine and Medical Specialities, Faculty of Medicine and Health Sciences, University of Alcalá, Alcalá de Henares, Madrid, Spain.
Basilio De la TorreService of Traumatology of University Hospital Ramón y Cajal, Madrid, Spain.

Funding

Molecular Basis of Berberine-Mediated Antitumor ActivityF05AT002014 · NCCIH · UNIVERSITY OF CHICAGO · PI KANG, QUAN · 2003 to 2007
$183k
MINECO (Spanish Ministry of Economy and Competitiveness) MAT2014-51918-C2-1-RMINECO (Spanish Ministry of Economy and Competitiveness) MAT-201784277-RMITIC-CM (Community of Madrid) B2017/BMD-3804NCCIH NIH HHS F05 AT002014SECOT (Spanish Society of Orthopedic Surgery and Traumatology) 2016/0055
6 · The paper itself

Abstract

Joint prostheses are an essential element to improve quality of life. However, prostheses may fail due to several factors, including the most frequent cause, Staphylococcus aureus infection. The identification of new fixing bone cements with less reactivity on bone tissue and an adequate response to infection remains a primary challenge. The aim of this study is to evaluate the response of bone tissue in rabbits after introduction of a hydroxyapatite-coated titanium rod with a commercial fixative cement (Palacos®) compared to a modified experimental cement (EC) containing polylactic-co-glycolic acid (PLGA) microspheres in the presence or absence of contaminating germs. This study used 20 New Zealand rabbits which were divided into four groups (n = 5) depending on the presence or absence of S. aureus and the use of commercial (Palacos®) or EC. A histological method, based on bone architecture damage, was proposed to evaluate from 1 to 9 the histological results and the response of the infected tissue. The macrophage response was also evaluated using monoclonal antibody RAM-11. The study showed better bone conservation with the use of EC with PLGA microspheres against the Palacos® commercial cement, including the noncontaminated and contaminated groups. © 2019 The Authors. Journal of Biomedical Materials Research Part B: Applied Biomaterials published by Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B:2517-2526, 2019.

Indexed as

Bone CementsBone Diseases, InfectiousMicrospheresPolylactic Acid-Polyglycolic Acid CopolymerStaphylococcal InfectionsAnimalsRabbitsStaphylococcus aureusBone CementsPolylactic Acid-Polyglycolic Acid Copolymerbiomaterialsmacrophagic responseosteomyelitisPLGA microspheresregenerative medicine

Identifiers

PMID30784189
PMCPMC6790951

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.